Stay updated on Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page.

Latest updates to the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now indicates that participant recruitment has closed and adds new help sections such as How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention header formatting changes from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check20 days agoChange DetectedRevision: v3.5.5 is now shown on the page, indicating a recent update to the study record. The change signals a refresh of the content but does not specify what was altered in this context.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page's revision tag has been updated from v3.5.3 to v3.5.4, indicating a recent behind-the-scenes update. This change affects only metadata and does not modify the study content or results presented on the page.SummaryDifference0.0%

- Check49 days agoChange DetectedTaoyuan District, Taiwan was replaced with Taoyuan, Taiwan in the study locations, with Taoyuan added and Taoyuan District removed. This update reflects a city-level designation in the site list to more accurately identify the participating location.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3. This indicates a build/version update for the page.SummaryDifference0.0%

- Check70 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2. No visible changes to study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page.